Humana Inc. (HUM) is a Medical - Healthcare Plans company in the Healthcare sector, currently trading at $196.21. It has a SharesGrow Score of 53/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of HUM = $1,449.84 (+638.9% from the current price, the stock appears undervalued). Analyst consensus target is HUM = $235 (+19.8% upside).
Valuation: HUM trades at a trailing Price-to-Earnings (P/E) of 19.8 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.3.
Financials: revenue is $129.7B, +11.8%/yr average growth. Net income is $1.2B, growing at -21.5%/yr. Net profit margin is 0.9% (thin). Gross margin is 14.5% (-85.5 pp trend).
Balance sheet: total debt is $12.9B against $17.7B equity (Debt-to-Equity (D/E) ratio 0.73, moderate). Current ratio is 0.72 (tight liquidity). Debt-to-assets is 26.5%. Total assets: $48.8B.
Analyst outlook: 13 / 44 analysts rate HUM as buy (30%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 86/100 (Pass), Growth 48/100 (Partial), Past 100/100 (Pass), Health 17/100 (Fail), Moat 45/100 (Partial), Future 46/100 (Partial), Income 30/100 (Fail).
